RELATING TO INSURANCE -- INSURANCE COVERAGE FOR MENTAL ILLNESS AND, SUBSTANCE USE DISORDERS
Impact
The proposed changes would significantly enhance access to mental health and substance use disorder treatment for Rhode Island residents. With mandated coverage parity, individuals suffering from these conditions would benefit from improved health insurance policies that conform to established standards of care. Additionally, the bill emphasizes the need for insurance payors to utilize criteria developed by recognized professional associations, promoting a standardized approach to treatment coverage that is aligned with best practices in healthcare.
Summary
House Bill H7944 seeks to amend existing provisions regarding insurance coverage for mental health and substance use disorders in Rhode Island. Introduced in January 2026, the bill mandates that all health insurance plans provide coverage for these conditions on terms that are equal to those offered for other medical conditions. This includes eliminating any annual or lifetime dollar limitations for treatment and ensuring that financial requirements applied to mental health services are no stricter than those for physical health services.
Contention
One notable point of contention surrounding H7944 is the potential implications for insurance companies and their cost structures. Some insurers may argue that increasing coverage and eliminating limitations could lead to higher premiums. Furthermore, while the bill is largely supported by mental health advocates as a necessary step for reducing stigma and improving care accessibility, concerns about the sustainability of such mandates on insurance models are likely to fuel discussions as the bill progresses through the legislative process.
Authorizes emergency medical service agencies to transport individuals to alternative facilities for treatment and permits licensed providers for mental health disorders to treat patients within the community.
Mandates all insurance contracts, plans or policies provide insurance coverage for the expense of diagnosing and treating infertility, for women between the ages of 25 and 42 years including preimplantation genetic diagnosis (PGD) in conjunction with IVF.
Residential Substance Use Disorder Treatment Act of 2023 This bill revises and reauthorizes through FY2027 grants for residential substance use disorder treatment programs at state and local correctional and detention facilities. Among the revisions, the bill replaces statutory references to substance abuse with substance use disorder, specifies that the term residential substance use disorder treatment program includes a medication-assisted treatment program, requires the chief medical officer or other staff overseeing a program to complete training on the science of addiction and the latest research and clinical guidance on treating substance use disorders in criminal justice settings, and allows people who are awaiting trial or in pretrial detention to participate in the programs.
Requiring licensure of outpatient substance use disorder treatment facilities and relative to complaint investigation of treatment facilities by the department of health and human services office of the ombudsman and making an appropriation therefor.
Establishing the Nonnarcotic Medication Substance Use Disorder Treatment Program; in organization and jurisdiction of courts of common pleas, providing for court assessments for substance use disorder treatment; in other criminal provisions, further providing for supervisory relationship to offenders; and, in Pennsylvania Board of Probation and Parole, further providing for supervisory relationship to offenders.